Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving gut health, according to a study published in The Journal of Clinical Investigation.
Jul 7, 2026
0
3
Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment monitoring of colorectal cancer (CRC), according to a new study, offering less invasive alternatives to traditional ...
Jul 6, 2026
0
4
Researchers from Ann & Robert H. Lurie Children's Hospital of Chicago identified a distinct subtype of eosinophilic esophagitis (EoE)—a chronic allergic inflammatory disorder in which the esophagus narrows, interfering with ...
Jul 6, 2026
0
8
A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal ...
Jul 6, 2026
0
4
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising early results when combined with standard first-line chemotherapy, according to research ...
Jul 5, 2026
0
11
Psychological stress is increasingly recognized as a risk factor for certain health conditions, including cardiovascular disease and diabetes, especially when paired with an impaired immune response. In a study in Cell Stem ...
Jul 2, 2026
0
9
In one of the most comprehensive studies of coffee and liver health to date, Cedars-Sinai Health Sciences University investigators linked higher coffee consumption with a lower risk of cirrhosis, liver cancer and liver-related ...
Jul 2, 2026
0
66
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...
Jul 1, 2026
0
5
Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not ...
Jul 1, 2026
0
8
Results of the ongoing eNRGy trial, a single-arm, multicenter, global Phase II clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable side effects and clinically ...
Jul 1, 2026
0
4
